XenoTherapeutics Company
XenoTherapeutics is a clinical-stage cell and gene therapy company engineering immune-compatible cells, tissues, and organs. XenoTherapeutics conducts all phases of clinical product development, from initial genome engineering to prototype design, from manufacturing to clinical evaluation. We Engineer Life. In 2019, XenoTherapeutics successfully completed the first ever FDA-cleared genetically engineered non-human organ transplant for investigational use.
Headquarters:
Boston, Massachusetts, United States
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Technology:
Others
Founded Date:
2016-01-04
Industry:
Gene therapy